Major fashion houses adopt digital product passports to track garments from atelier to resale Luxury leaders are turning garments into data-rich assets that tell their complete life story. Digital product…
Breakthrough blood test detects early-stage pancreatic cancer with unprecedented accuracy in a multicenter clinical trial A new blood test has demonstrated remarkable accuracy for detecting early-stage pancreatic cancer. Investigators reported…
Urban streets face mounting pressure from population growth, delivery traffic, and rising travel demand. Traditional timing plans struggle to keep pace. Engineers now deploy artificial intelligence to manage traffic signals…
Solid-state batteries are moving closer to electric vehicles. A new wave of results shows meaningful progress. Researchers engineered interfaces that carry higher currents without shorting. Automakers now see faster charging…
COP30 opened in Belém with a global pact to fund Amazon protection and indigenous-led conservation initiatives. Delegates highlighted the rainforest’s central role in stabilizing climate and sustaining livelihoods across South…
Researchers have crossed a critical threshold for solar conversion efficiency. A perovskite‑silicon tandem solar cell has surpassed 33% in independent testing. Accredited laboratories validated the result under standard test conditions.…
A leading battery developer reports a solid‑state cell that endures 1,000 fast‑charge cycles with minimal degradation. The result targets the toughest EV requirement: frequent rapid charging with long service life.…
Researchers have unveiled a sodium-sulfur battery prototype that targets high energy density without using rare metals. The design leverages abundant elements to cut material risk and improve supply chain resilience.…
Electric vehicles are gaining a powerful new advantage with cobalt-free batteries that charge in about ten minutes. These chemistries reduce reliance on costly and controversial metals without sacrificing performance. They…
Researchers reported encouraging vision gains from the first-in-human trial of an in vivo CRISPR therapy for inherited blindness. The therapy targeted a severe retinal disorder and produced measurable improvements in…
